THERESE ROCHE: Open Payments
NPI 1740460286 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 31 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,241
Food & beverage: $1,049Education: $192
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $238 |
| AstraZeneca Pharmaceuticals LP | 4 | $165 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $124 |
| Exact Sciences Corporation | 1 | $107 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $103 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Incyte Corporation | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $45 |
| Genentech USA, Inc. | 2 | $40 |
Products named: Trodelvy, ZYNLONTA, The Cologuard Plus Collection Kit, DATROWAY, KISQALI, MONJUVI, ERLEADA, VERZENIO.
Industry payments across IL — which companies pay providers there.
